Topic

SR9009 (Stenabolic)

Articles exploring SR9009, its role in metabolic and mitochondrial pathways, and findings from preclinical research. 5 guides, each with its sources.

Start with these

SR9009 Stenabolic REV-ERB agonist (body-clock and metabolic modulator) SR9009, sold as Stenabolic, is not a SARM. It switches on REV-ERB, a body-clock protein that also controls fat and sugar metabolism. Scripps Research scientists described it in 2012 as a research compound, and… Half-lifeNot established Furthest trialNone WADAProhibited EvidenceLiver load Open the fact sheet

Guide

SR9011 Review: Dosage, Before and After, Side Effects

SR9011 review: a REV-ERB agonist tested only in mice and cells. What it did there, reported doses, before and after expectations, legality and side…

Published 9 Apr 2024 5 min read

Question

Stenabolic (SR9009) Dosage: What Users Report and What Is Known

There is no human SR9009 dosage from research. Users report 20–30 mg a day, split; the studies were in mice, by injection.

Published 8 Apr 2024 5 min read

All guides

Fact sheet